Learning objectives

After watching the webinar, participants will:

understand the major sensitivity deficit of most currently used POC cTnT/I assays and the clinical consequences – second blood sampling at 6h;
be able to identify the possibility for reducing turn-around time when using POC vs. central lab;
know the assay-specific performance data (and their limitations) for the first commercially available POC hs-cTnI assays, including their assay-specific ESC hs-cTnI 0/1h-algorithms; and
be able to appreciate the opportunity and emerging data for other POC CV biomarkers.